Table 2.
Treatment group | Duration (median number of days) | Scores totaled across days 43–54 (mean) | Mitigated fraction†† for total score (95% CI‡) (vs. T01) |
---|---|---|---|
T01 | 11.00 | 13.29 | – |
T02 | 1.00* | 1.75* | 0.7143 (0.3618, 1.0000) |
T03 | 1.00* | 2.25*a | 0.6964 (0.3251, 1.0000) |
T04 | 7.00† | 13.63†b | −0.2321 (−0.8350, 0.3708) |
Overall treatment P-value | 0.0003 | 0.0001 |
Mitigated fraction = the probability that a vaccinate will be less affected by challenge than a non-vaccinate. T01, Control Group. T02, Bronchicine CAe. T03, BbBG-7. T04, BbBG-5.
vs. T01, P < 0.10.
vs. T02, P < 0.10.
Confidence interval.
Among groups 2–4.
Values with no common letters are significantly different at P <0.10.